OPKO Health (OPK)
1.46
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form DEFA14A OPKO HEALTH, INC.
May 15, 2026 4:44 PM - SEC Filing
OPKO's ModeX to present CAR-T cell generation data at gene therapy meeting
May 12, 2026 8:00 AM - StreetInsider
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
May 12, 2026 8:00 AM - Globe NewsWire
Form ARS OPKO HEALTH, INC. For: Dec 31
April 30, 2026 4:06 PM - SEC Filing
Form DEFA14A OPKO HEALTH, INC.
April 30, 2026 4:05 PM - SEC Filing
Form DEF 14A OPKO HEALTH, INC. For: Apr 30
April 30, 2026 4:03 PM - SEC Filing
OPKO Health receives 15% stake in Nicoya for China drug rights
April 30, 2026 8:31 AM - StreetInsider
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
April 30, 2026 8:30 AM - Globe NewsWire
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
April 30, 2026 8:00 AM - Globe NewsWire
Barrington Research Downgrades Opko Health (OPK) to Market Perform
April 29, 2026 7:38 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
April 29, 2026 7:22 AM - StreetInsider
OPKO Health (OPK) Misses Q1 EPS by 1c, provides guidance
April 28, 2026 4:10 PM - StreetInsider
Form 10-Q OPKO HEALTH, INC. For: Mar 31
April 28, 2026 4:10 PM - SEC Filing
Form 8-K OPKO HEALTH, INC. For: Apr 28
April 28, 2026 4:07 PM - SEC Filing
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
April 28, 2026 4:05 PM - Globe NewsWire
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
April 22, 2026 8:02 AM - Globe NewsWire
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026
April 21, 2026 4:05 PM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
April 9, 2026 6:41 AM - StreetInsider
OPKO Health's ModeX begins phase 1 trial of COVID-19 prevention drug
April 8, 2026 8:03 AM - StreetInsider
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19
April 8, 2026 8:00 AM - Globe NewsWire
Form 4 OPKO HEALTH, INC. For: Mar 20 Filed by: PAGANELLI JOHN A
March 20, 2026 4:25 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Mar 18 Filed by: UPPALURI SUBBARAO V
March 20, 2026 4:17 PM - SEC Filing
Form 3 OPKO HEALTH, INC. For: Mar 18 Filed by: UPPALURI SUBBARAO V
March 20, 2026 4:10 PM - SEC Filing
Form 8-K OPKO HEALTH, INC. For: Mar 18
March 19, 2026 4:50 PM - SEC Filing
Full Article List
